
Study Unlikely To Achieve Primary Efficacy Endpoint; DMC Recommends Discontinuation of Study No Unexpected ...

BATON ROUGE, La., Jan. 09, 2019 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" ...
Click to continue to site. Closing